Abstract
Choroidal neovascularization (CNV) is quite rare in children and adolescents. In this young population, CNV has been reported in association with infection, inflammation, optic disc anomalies, retinal dystrophies, disruption of Bruch’s membrane, choroidal tumors, and trauma. Often, no cause is found and the CNV is said to be idiopathic (Sivaprasad and Moore, Br J Ophthalmol 92(4):451–454, 2008; Goshorn et al., J Pediatr Ophthalmol Strabismus 32(3):178–182, 1995; Spaide, Curr Opin Ophthalmol 10:177–181, 1999). Laser photocoagulation, photodynamic therapy with verteporfin, and submacular surgery have been employed successfully for the treatment of pediatric CNVs. However, anti-VEGF therapy and PDT remains the preferred treatment options.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sivaprasad S, Moore AT. Choroidal neovascularisation in children. Br J Ophthalmol. 2008;92(4):451–4.
Goshorn EB, Hoover DL, Eller AW, Friberg TR, Jarrett WH, Sorr EM. Subretinal neovascularization in children and adolescents. J Pediatr Ophthalmol Strabismus. 1995;32(3):178–82.
Spaide RF. Choroidal neovascularization in younger patients. Curr Opin Ophthalmol. 1999;10:177–81.
Wilson ME, Mazur DO. Choroidal neovascularization in children: report of five cases and literature review. J Pediatr Ophthalmol Strabismus. 1988;25(1):23–9.
Prasad AG, Van Gelder RN. Presumed ocular histoplasmosis syndrome. Curr Opin Ophthalmol. 2005;16(6):364–8.
Mavrikakis E, Levin AV, Lam WC. Choroidal neovascularization secondary to congenital toxoplasmosis in an infant. Can J Ophthalmol. 2010;45(6):e11–2.
Ketata A, Ben Zina Z, Hajji D, Sellami D, Abdelkefi A, Kharrat W, et al. Two cases of subretinal neovascular membrane in Vogt-Koyanagi-Harada syndrome. J Fr Ophtalmol. 2006;29(3):302–6.
Ozdek S, Ozmen MC, Tufan HA, Gurelik G, Hasanreisoglu B. Photodynamic therapy for best disease complicated by choroidal neovascularization in children. J Pediatr Ophthalmol Strabismus. 2012;49(4):216–21.
Secretan M, Sickenberg M, Zografos L, Piguet B. Morphometric characteristics of traumatic choroidal ruptures associated with neovascularization. Retina. 1998;18:62–6.
Patel MM, Chee YE, Eliott D. Choroidal rupture: a review. Int Ophthalmol Clin. 2013;53(4):69–78.
Tilleul J, Mimoun G, Querques G, Puche N, Zerbib J, Lalloum F, et al. Intravitreal ranibizumab for choroidal neovascularization in angioid streaks: four year follow-up. Retina. 2016;36(3):483–91.
Rishi P, Gupta A, Rishi E, Shah BJ. Choroidal neovascularization in 36 eyes of children and adolescents. Eye (Lond). 2013;27(10):1158–68.
Potter MJ, Szabo SM, Ho T. Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl. Graefes Arch Clin Exp Ophthalmol. 2006;244(5):639–41.
Secretan M, Kuhn D, Soubrane G, Coscas G. Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol. 1997;7:307–16.
Erkkilä H. Clinical appearance of optic disc drusen in childhood. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975;193(1):1–18.
Basdekidou C, Caputo G. Optic nerve abnormalities in pediatric ocular diseases. In: Hartnett ME, Trese M, Capone A, BJB K, Steidl SM, editors. Pediatric retina. 2nd ed. Philadelphia: Wolters Kluver, Lippincott Williams & Wilkins; 2014. p. 148–72.
Daruich AL, Moulin AP, Tran HV, Matet A, Munier FL. Subfoveal nodule in Coats’ disease: toward an updated classification predicting visual prognosis. Retina. 2017;37(8):1591–8.
Shields CL, Sun H, Demirci H, Shields JA. Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch Ophthalmol. 2005;123(12):1658–66.
Hollander DA, Stewart JM. Acquired and other retinal diseases. In: Lambert SR, Lyons CJ, editors. Taylor & Hoyt’s pediatric ophthalmology and strabismus. 4th ed. Philadelphia: Elsevier; 2013. p. 522–9.
Lupidi M, Cerquaglia A, Chhablani J, Fiore T, Singh SR, Cardillo Piccolino F, et al. Optical coherence tomography angiography in age-related macular degeneration: the game changer. Eur J Ophthalmol. 2018;28(4):349–57.
Sodi A, Murro V, Caporossi O, Passerini I, Bacci GM, Caputo R, et al. Long-term results of photodynamic therapy for choroidal neovascularization in pediatric patients with best Vitelliform Macular Dystrophy. Ophthalmic Genet. 2015;36(2):168–74.
Sears J, Capone A Jr, Aaberg T Sr, Lewis H, Grossniklaus H, Sternberg P Jr, et al. Surgical management of subfoveal neovascularization in children. Ophthalmology. 1999;106(5):920–4.
Uemura A, Thomas MA. Visual outcome after surgical removal of choroidal neovascularization in pediatric patients. Arch Ophthalmol. 2000;118(10):1373–8.
Kohly RD, Muni RH, Kertes PJ, Lam WC. Management of pediatric choroidal neovascular membranes with intravitreal anti-VEGF agents: a retrospective consecutive case series. Can J Ophthalmol. 2011;46:46–50.
Rich R, Vanderveldt S, Berrocal AM, Mavrofrides EC, Murray TG, Gregori N. Treatment of choroidal neovascularization associated with Best’s disease in children. J Pediatr Ophthalmol Strabismus. 2009;46:306–11.
Baillif S, Nguyen E, Colleville-El Hayek A, Betis F. Long term follow-up after single intravitreal ranibizumab injection for choroidal neovascularization secondary to optic nerve head drusen in a 5-year old child. Graefes Arch Clin Exp Ophthalmol. 2013;251:1657–9.
Vayalambrone D, Misra A. Paediatric choroidal osteoma treated with ranibizumab. BMJ Case Rep. 2012; https://doi.org/10.1136/bcr-2012-007446.
Benevento J, Jager RD, Noble AG, Latkany P, Mieler WF, Sautter M, et al. Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol. 2008;126:1152–6.
Piermarocchi S, Benetti E, Fracasso G. Intravitreal bevacizumab for posttraumatic choroidal neovascularization in a child. J AAPOS. 2011;15:314–6.
Henry CR, Sisk RA, Tzu JH, Albini TA, Davis JL, Murray TG, et al. Long-term follow-up of intravitreal bevacizumab for the treatment of pediatric retinal and choroidal diseases. J AAPOS. 2015;19(6):541–8.
Kozak I, Mansour A, Diaz RI, Calzada JI, Pichi F, Cruz-Villegas V, et al. Outcomes of treatment of pediatric choroidal neovascularization with intravitreal antiangiogenic agents. Retina. 2014;34:2044–52.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Özdek, Ş., Atalay, H.T. (2020). Choroidal Neovascularization in Pediatric Population. In: Chhablani, J. (eds) Choroidal Neovascularization. Springer, Singapore. https://doi.org/10.1007/978-981-15-2213-0_17
Download citation
DOI: https://doi.org/10.1007/978-981-15-2213-0_17
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2212-3
Online ISBN: 978-981-15-2213-0
eBook Packages: MedicineMedicine (R0)